There is a medical need for antibacterial agents that do not damage the resident gut microbiota or promote the spread of antibiotic resistance. We recently described a prototypic precision bactericidal agent, Av-CD291.2, which selectively kills specific
No takes yet. Share an insight, caveat, or question.
Kirk et al. (2017) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: